Post Categories
Blog post not found!
New Study Illuminates COVID-19 Neurological Symptoms
May 19, 2021
Difficulty thinking, concentrating, and remembering are amongst the most debilitating long-haul symptoms of COVID-19. In some cases, this “brain fog” can linger for months….
Understanding How Cells Tell RNA and DNA Apart Could Lead to New Antivirals
May 17, 2021
RNA viruses are known to cause a large number of diseases in humans, including COVID-19, measles, influenza, hepatitis, yellow fever and Zika. Most new…
The Need Grows for New Antifungal Therapies
May 10, 2021
Unless you’re working in a highly controlled environment like a cleanroom, it’s safe to assume you are surrounded by fungi. Millions of fungal species…
The Most Effective COVID-19 Vaccine Could Be Intranasal
May 3, 2021
The pace of vaccine development against COVID-19 will certainly go down as one of the fastest in our history. In less than a year,…
Human Immune System Beats HIV for the First Time
April 29, 2021
The Centers for Disease Control and Prevention (CDC) describes human immunodeficiency virus (HIV) as a virus that attacks the body’s immune system. Without treatment, HIV can…
Five Criteria to Use When Selecting a CRO for a Gene Therapy Study
April 26, 2021
Contract research organizations (CROs) have been an integral part of drug development since the 1920s, first as providers of preclinical testing services, then as…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
NEWARK, Delaware, November 13, 2024/BUSINESS WIRE/ — QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy…
